The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,310.00
Bid: 2,320.00
Ask: 2,325.00
Change: 0.00 (0.00%)
Spread: 5.00 (0.216%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,310.00
OXIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Chairman’s AGM Statement 2020

8 Sep 2020 07:00

RNS Number : 2747Y
Oxford Instruments PLC
08 September 2020
 

 

 

Oxford Instruments plc

Chairman's AGM Statement 2020

 

Oxford Instruments plc, a leading provider of high technology products and services to industrial companies and scientific research communities, is holding its Annual General Meeting today at which the Chairman, Neil Carson, will make the following statement on trading:

 

The coronavirus has continued to have an impact on trading in the first five months of the year, with cumulative revenue down 2% against last year. Revenue has been supported by a strong uplift in shipments of our compound semiconductor process solutions and installations of cryogenic and magnet systems, in addition to the carry-over of systems that we were unable to ship or install in the final weeks of the last financial year due to the closure of customer sites and travel restrictions. This has partially offset lower revenue to academic markets for our scientific cameras, microscopy products and electron analysers, due to continued disruption across these customers.

 

Although there remains considerable uncertainty as to the future impact and longevity of covid-19 disruption, we have seen modest order growth over the first five months of trading and a good improvement in the order book. Strong order growth across commercial customers, particularly from our compound semiconductor process solutions, has offset a small decline in orders from academic customers, where we are seeing a slower rate of recovery.

 

The Group's robust trading performance and focus on protecting its strong balance sheet has resulted in an improvement in net cash to £70.0m as at 7 September 2020 (31 March 2020: £67.5m), in accord with normal seasonal trading patterns.

 

Oxford Instruments' results for the half year ended 30 September 2020 will be released on 10 November 2020.

 

 

 

Enquiries:

 

Oxford Instruments plc Tel: 01865 393200

Ian Barkshire, Chief Executive

Gavin Hill, Group Finance Director

 

MHP Communications Tel: 020 3128 8591

Rachel Hirst/Alice McLaren

 

 

 

- Ends -

Issued for and on behalf of Oxford Instruments plc

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for 60 years, supporting its core purpose to address some of the world's most pressing challenges. 

 

The first technology business to be spun out from Oxford University, Oxford Instruments is now a global company and is listed on the London Stock Exchange (OXIG). Its strategy focuses on being a customer-centric, market-focused Group, understanding the technical and commercial challenges faced by its customers. Key market segments include Semiconductor & Communications, Advanced Materials, Healthcare & Life Science, and Quantum Technology.

 

Their portfolio includes a range of core technologies in areas such as low temperature and high magnetic field environments; Nuclear Magnetic Resonance; X-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; and advanced growth, deposition and etching.

 

Oxford Instruments is helping enable a greener economy, increased connectivity, improved health and leaps in scientific understanding. Their advanced products and services allow the world's leading industrial companies and scientific research communities to image, analyse and manipulate materials down to the atomic and molecular level, helping to accelerate R&D, increase manufacturing productivity and make ground breaking discoveries.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDZGGLVNFGGZM
Date   Source Headline
1st May 202410:12 amRNSTotal Voting Rights
24th Apr 20244:31 pmPRNHolding(s) in Company
24th Apr 20244:29 pmPRNHolding(s) in Company
16th Apr 20247:00 amRNSTrading Update
11th Apr 202412:54 pmPRNDirector/PDMR Shareholding
2nd Apr 202410:32 amPRNTotal Voting Rights
20th Mar 20244:26 pmPRNDirector/PDMR Shareholding
12th Mar 20248:30 amPRNDirector/PDMR Shareholding
1st Mar 20248:00 amPRNTotal Voting Rights
28th Feb 202411:25 amPRNHolding(s) in Company
12th Feb 20244:15 pmPRNDirector/PDMR Shareholding
1st Feb 20249:10 amPRNTotal Voting Rights
19th Jan 202411:30 amPRNHolding(s) in Company
11th Jan 20244:25 pmPRNDirector/PDMR Shareholding
10th Jan 20247:00 amRNSAcquisition of First Light Imaging SAS
2nd Jan 20241:31 pmPRNBlocklisting - Interim Review
2nd Jan 20241:19 pmPRNTotal Voting Rights
12th Dec 20239:00 amPRNDirector/PDMR Shareholding
1st Dec 20239:00 amPRNTotal Voting Rights
22nd Nov 20232:01 pmPRNAppointment of Independent Non-Executive Director
15th Nov 20234:42 pmPRNDirector/PDMR Shareholding
15th Nov 202312:29 pmPRNDirector/PDMR Shareholding
14th Nov 20237:00 amRNSHalf-Year Results
13th Nov 20231:37 pmPRNDirector/PDMR Shareholding
1st Nov 20239:00 amPRNTotal Voting Rights
17th Oct 20234:13 pmPRNHolding(s) in Company
12th Oct 20234:03 pmPRNDirector/PDMR Shareholding
12th Oct 20237:00 amRNSHalf Year Trading Update
11th Oct 20239:32 amPRNDirector/PDMR Shareholding
2nd Oct 20238:53 amPRNTotal Voting Rights
27th Sep 20234:19 pmPRNDirector/PDMR Shareholding
25th Sep 20234:20 pmPRNDirector/PDMR Shareholding
19th Sep 20231:41 pmPRNAnnual General Meeting 2023 Results
14th Sep 20237:00 amPRNBlock Listing Application
12th Sep 20233:27 pmPRNDirector/PDMR Shareholding
10th Aug 20232:16 pmPRNDirector/PDMR Shareholding
7th Aug 202310:35 amPRNHolding(s) in Company
1st Aug 20232:16 pmRNSTotal Voting Rights
27th Jul 20234:59 pmRNSHolding(s) in Company
27th Jul 20231:51 pmRNSCEO succession update
26th Jul 20235:12 pmRNSDirector/PDMR Shareholding
26th Jul 202311:15 amRNSHolding(s) in Company
25th Jul 202312:44 pmRNSDirector/PDMR Shareholding
20th Jul 202310:23 amPRNPublication of Annual Report and Notice of AGM 2023
10th Jul 20233:26 pmPRNDirector/PDMR Shareholding
6th Jul 20237:00 amRNSAnnual General Meeting: revised date
3rd Jul 20232:37 pmPRNBlocklisting - Interim Review
3rd Jul 20231:39 pmPRNTotal Voting Rights
13th Jun 20237:00 amRNSPreliminary Results
13th Apr 20237:00 amRNSCEO succession

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.